In May this year, I argued that Barclays (NYSE: BCS ) stock is "well on track to deliver triple-digit upside", highlighting a cheap valuation against strong, and improving commercial momentum. Today, reflecting on a solid Q3 print, I am reiterating my bullish stance on theExperience as an investment analyst for a major BB-Bank, as well as private equity consultant for MBB. Currently working towards the CFA charter, having completed I&II. Passion for risk-assets (Growth, Contrarian, Emerging Market) ex-colle ...

Core Viewpoint - Barclays PLC is planning to re-enter the Saudi Arabian market to leverage the kingdom's increasing demand for global capital market access, as stated by CEO C.S. Venkatakrishnan [1]. Group 1: Barclays' Strategy in Saudi Arabia - The bank aims to expand its team in the Middle East, focusing on cities like Dubai, Abu Dhabi, and Riyadh [2]. - Barclays previously assisted Saudi Arabia's Public Investment Fund in issuing a two-part sterling-denominated bond, raising approximately £650 million ($844 million) [2]. - The focus of Barclays' re-entry will be on investment banking and trading, alongside potential corporate banking work [3]. Group 2: Growth Initiatives - Barclays has initiated a three-year plan to enhance the profitability of its investment banking division, which includes trading, advisory, and capital markets origination [4]. - The investment banking division has shown positive year-over-year results, with the CEO expressing encouragement about the progress made so far [5]. Group 3: Market Context - Barclays' potential return to Saudi Arabia follows a decade-long absence, aligning with a global trend of banks expanding operations in the oil-rich kingdom, which is undergoing a significant economic transformation valued at a trillion dollars [5]. - Other financial firms, such as BlackRock and Franklin Resources, are also making strides in Saudi Arabia, indicating a growing interest in the region [6][7].

Analyst's Disclosure: I/we have a beneficial long position in the shares of BCS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. This writing is for informational purposes only. All opinions expressed herein are not investment recommendations, and are not meant to be reli ...

Core Viewpoint - Barclays PLC (NYSE: BCS) is currently trading at a relatively low valuation and has shown positive performance in Q3 2024, but a re-rating of its shares is not expected to occur in the near future [1] Financial Performance - The company reported a positive performance in Q3 2024, indicating resilience in its financial metrics [1] Valuation - Barclays is noted to be trading at a low valuation compared to its peers, which may present an opportunity for investors [1]

Exhibit 99.1 Barclays PLC This exhibit includes portions from the previously published Results Announcement of Barclays PLC relating to the nine months ended 30 September 2024, as amended in part to comply with the requirements of Regulation G and Item 10(e) of Regulation S-K promulgated by the US Securities and Exchange Commission (SEC), including the reconciliation of certain financial information to comparable measures prepared in accordance with International Financial Reporting Standards (IFRS). The pu ...

Barclays PLC (NYSE:BCS) Q3 2024 Earnings Conference Call October 24, 2024 4:30 AM ET Company Participants C.S. Venkatakrishnan - Group Chief Executive Angela Cross - Group Finance Director Conference Call Participants Jason Napier - UBS Benjamin Toms - RBC Chris Cant - Autonomous Edward Firth - KBW Guy Stebbings - BNP Paribas Amit Goel - Mediobanca Chris Hallam - Goldman Sachs Alvaro Serrano - Morgan Stanley Robin Down - HSBC Perlie Mong - Bank of America Merrill Lynch Andrew Coombs - Citi Group Operator We ...

Barclays’ (BCS) third-quarter 2024 net income attributable to ordinary equity holders of £1.56 billion ($2.03 billion) grew 23% year over year.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Shares of BCS on NYSE gained 4% in pre-market trading as profit increased. Investors also cheered an upward tweak in net interest income (NII) 2024 guidance.An increase in revenues (driven by solid investment banking performance), stable operating expenses (showing the success of cost-efficiency ...

LONDON — British bank Barclays on Thursday reported £1.6 billion ($2 billion) net profit attributable to shareholders for the third quarter, beating expectations.The result compared with the £1.17 billion net profit forecast in an LSEG poll of analysts, and was 23% higher than the same period in 2023.Revenue for the period came in at £6.5 billion, slightly ahead of a forecast of £6.39 billion.The lender's return on tangible equity rose to 12.3% from 9.9% in the second quarter, as its CET1 ratio — a measure ...

Barclays US Consumer Bank will become the exclusive issuer of General Motors' GM Rewards Mastercard and GM Business Mastercard in the United States in the summer of 2025 and will acquire the card program's receivables from the current issuer — Goldman Sachs — next year. The bank and the automaker announced their new long-term partnership agreement in a Monday (Oct. 14) press release. "As a leading and experienced player in the U.S. partner card market with a winning formula for growing partner programs, we ...

Barclays upgraded CVS Health Inc CVS on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage.Despite macroeconomic pressures impacting the retail pharmacy sector, the analyst writes that CVS has shown resilience thanks to its diversified business model.Also Read: CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit.This has allowed the company to mitigate some of these challenges and c ...